SOURCE: Vet-Stem
POWAY, CA–(Marketwire – December 1, 2010) – Vet-Stem, the world’s leading Regenerative Veterinary Medicine™ company, is pleased to announce a new milestone of 4,000 horses treated with Vet-Stem Cell therapy.
Vet-Stem began providing stem cells to veterinarians in 2004 and has now provided stem cells for the treatment of 4,000 horses. Greater than 75% of horses treated with Vet-Stem Cell therapy for tendon and ligament injuries are able to return to their previous level of performance. What was a new treatment option in 2004 has become the gold standard for performance horses with tendon and ligament injuries.
“We are proud that so many horse owners and veterinarians have placed their trust in Vet-Stem Cell therapy. We feel a great sense of accomplishment knowing that there are thousands of horses and horse owners who have experienced the benefit of stem cell technology. This practical and beneficial application of technology puts stem cell therapy into the present day instead of a future theoretical concept,” said Bob Harman, DVM, MPVM, Founder and CEO of Vet-Stem.
Vet-Stem has also provided stem cells for thousands of dogs with arthritis with a similar success rate. The rapid adoption of stem cell therapy by equine veterinarians and horse owners provided a springboard for use in small animal veterinary medicine. Vet-Stem is now working with small animal veterinarians to develop uses for stem cell therapy for injuries and diseases that currently have few treatment options.
More information about Vet-Stem can be found at www.Vet-Stem.com.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. Vet-Stem has exclusive licenses to over 50 patents including worldwide veterinary rights for use of adipose derived stem cells.
Click here to see all recent news from this company